SCHEMBL6538741

SCHEMBL6538741

CC1(C)OC[C@H](Cc2ccc(NC(=O)c3ccccc3)cc2)N1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 5/20 0.46
PPARG P37231 2/20 0.46
CCR2 P41597 1/20 0.45
CACNA1B Q00975 1/20 0.45
APBA1 Q02410 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
ALDH1A1 P00352 3/20 0.44
POLB P06746 3/20 0.44
HPGD P15428 1/20 0.44
NPC1 O15118 3/20 0.43
MAPT P10636 3/20 0.43
RAB9A P51151 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.42
APEX1 P27695 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6538746 1.00 PPARA (0.46) PPARAPPARGCCR2CACNA1BAPBA1
SCHEMBL17135524 0.80 NPC1 (0.47) CCR2NPC1RAB9A
SCHEMBL17135523 0.80 NPC1 (0.47) CCR2NPC1RAB9A
SCHEMBL6541442 0.80 CAPN1 (0.38) PPARGKMT2AALDH1A1HPGDMAPT
SCHEMBL6541438 0.80 CAPN1 (0.38) PPARGKMT2AALDH1A1HPGDMAPT
SCHEMBL6541124 0.79 NAMPT (0.42) ALDH1A1
SCHEMBL6541226 0.79 ALDH1A1 (0.39) ALDH1A1HPGDMAPTSMN1; SMN2
SCHEMBL6541119 0.79 NAMPT (0.42) ALDH1A1
SCHEMBL6539545 0.75 CACNA1G (0.43) MEN1KMT2AALDH1A1NPC1MAPT
SCHEMBL6186251 0.74 KCNH2 (0.42) MEN1KMT2AALDH1A1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6826033-B2 BETA 3 ADRENERGIC RECEPTOR AGONISTS; TREATMENT OF POLLAKIURIA, URINARY INCONTINENCE, OBESITY OR DIABETES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-11-30 US disclosed
US-20040037022-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-02-26 US disclosed